Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Louis G Lange

Director at NewAmsterdam Pharma Co N.V. (NAMS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 12SEC NAMSNewAmsterdam Pharma Co N.V. Sell 44,17310,806 held (−80%) $30.41 $1.3M -34.8%
Mar 12SEC NAMSNewAmsterdam Pharma Co N.V. Sell 44610,360 held (−4%) $31.23 $14K -36.5%
Mar 10SEC NAMSNewAmsterdam Pharma Co N.V. Sell 28,186 $29.41 $829K -32.6%
  • Sell

    Director Louis G Lange sold $1.3M of NAMS at $30.41 — cuts the stake by 80%.